» Articles » PMID: 32267831

Downregulation of LncRNA NORAD Promotes Ox-LDL-induced Vascular Endothelial Cell Injury and Atherosclerosis

Overview
Specialty Geriatrics
Date 2020 Apr 9
PMID 32267831
Citations 68
Authors
Affiliations
Soon will be listed here.
Abstract

Long noncoding RNAs (lncRNAs) play important roles in the development of vascular diseases. However, the effect of lncRNA NORAD on atherosclerosis remains unknown. This study aimed to investigate the effect NORAD on endothelial cell injury and atherosclerosis. Ox-LDL-treated human umbilical vein endothelial cells (HUVECs) and high-fat-diet (HFD)-fed ApoE mice were used as and models. Results showed that NORAD-knockdown induced cell cycle arrest in G0/G1 phase, aggravated ox-LDL-induced cell viability reduction, cell apoptosis, and cell senescence along with the increased expression of Bax, P53, P21 and cleaved caspase-3 and the decreased expression of Bcl-2. The effect of NORAD on cell viability was further verified via NORAD-overexpression. NORAD- knockdown increased ox-LDL-induced reactive oxygen species, malondialdehyde, p-IKBα expression levels and NF-κB nuclear translocation. Proinflammatory molecules ICAM, VCAM, and IL-8 were also increased by NORAD- knockdown. Additionally, we identified the strong interaction of NORAD and IL-8 transcription repressor SFPQ in HUVECs. In ApoE mice, NORAD-knockdown increased the lipid disorder and atherosclerotic lesions. The results have suggested that lncRNA NORAD attenuates endothelial cell senescence, endothelial cell apoptosis, and atherosclerosis via NF-κB and p53-p21 signaling pathways and IL-8, in which NORAD-mediated effect on IL-8 might through the direct interaction with SFPQ.

Citing Articles

Identification and Analysis of the Role of Zinc Finger Protein 580 in Ischemeia-Reperfusion Injury through Bioinformatics and Experimental Verification.

Zhang Z, Qin X, Liu J, Yan Z, Xie H, Zhang M ACS Omega. 2025; 10(8):8374-8387.

PMID: 40060886 PMC: 11886905. DOI: 10.1021/acsomega.4c10288.


Recent Advances in the Mutual Regulation of m6A Modification and Non-Coding RNAs in Atherosclerosis.

Wang Y, Ling S, Feng H, Hua J, Han Z, Chai R Int J Gen Med. 2025; 18:1047-1073.

PMID: 40026815 PMC: 11871936. DOI: 10.2147/IJGM.S508197.


Theoretical and Experimental Studies of the Dynamic Damage of Endothelial Cellular Networks Under Ultrasound Cavitation.

Xia C, Hu J, Zhou K, Li Y, Yuan S, Li Q Cell Mol Bioeng. 2025; 18(1):15-28.

PMID: 39949493 PMC: 11813858. DOI: 10.1007/s12195-024-00834-x.


pH-sensitive nano-drug delivery systems dual-target endothelial cells and macrophages for enhanced treatment of atherosclerosis.

Deng Y, Liu L, Li Y, Ma H, Li C, Yan K Drug Deliv Transl Res. 2025; .

PMID: 39881105 DOI: 10.1007/s13346-025-01791-2.


MiR-125b-5p ameliorates ox-LDL-induced vascular endothelial cell dysfunction by negatively regulating TNFSF4/TLR4/NF-κB signaling.

He W, Zhao L, Wang P, Ren M, Han Y BMC Biotechnol. 2025; 25(1):11.

PMID: 39856662 PMC: 11760099. DOI: 10.1186/s12896-025-00944-y.


References
1.
Guo X, Wang L, Xia X, Wang P, Li X . Effects of atorvastatin and/or probucol on recovery of atherosclerosis in high-fat-diet-fed apolipoprotein E-deficient mice. Biomed Pharmacother. 2018; 109:1445-1453. DOI: 10.1016/j.biopha.2018.10.184. View

2.
Lee S, Kopp F, Chang T, Sataluri A, Chen B, Sivakumar S . Noncoding RNA NORAD Regulates Genomic Stability by Sequestering PUMILIO Proteins. Cell. 2016; 164(1-2):69-80. PMC: 4715682. DOI: 10.1016/j.cell.2015.12.017. View

3.
Li Y, Yang C, Zhang L, Yang P . MicroRNA-210 induces endothelial cell apoptosis by directly targeting PDK1 in the setting of atherosclerosis. Cell Mol Biol Lett. 2017; 22:3. PMC: 5415835. DOI: 10.1186/s11658-017-0033-5. View

4.
Lin Z, Ge J, Wang Z, Ren J, Wang X, Xiong H . Let-7e modulates the inflammatory response in vascular endothelial cells through ceRNA crosstalk. Sci Rep. 2017; 7:42498. PMC: 5307339. DOI: 10.1038/srep42498. View

5.
Wang Y, Song X, Li Z, Liu B . Long non-coding RNAs in coronary atherosclerosis. Life Sci. 2018; 211:189-197. DOI: 10.1016/j.lfs.2018.08.072. View